Your session is about to expire
← Back to Search
Venlafaxine for Meniere's Disease
Study Summary
This trial will test if venlafaxine is an effective treatment for Meniere's disease. The study is double-blind, meaning neither the participants nor the researchers will know who is receiving the real drug or the placebo.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2009 Phase 4 trial • 220 Patients • NCT00177671Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: Venlafaxine Arm
- Group 2: Placebo
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Could you please provide a brief overview of other research projects that have included Venlafaxine?
"At this moment, there are 10 ongoing Venlafaxine trials with 4 in Phase 3. Most of these clinical studies are based in Charleston, South carolina; however, 23 different locations are running Venlafaxine trials."
Has this type of treatment been tested before?
"Since its inception in 2013, Venlafaxine has been under continuous research and evaluation. After the first clinical trial of 300 patients in 2013-- which was sponsored by Jiangsu Hansoh Pharmaceutical Co., Ltd.--Venlafaxine received approval for Phase 2 & 3 drugs. As of now, there are 10 active studies being conducted across 19 cities in 2 nations."
How many people have signed up for this clinical trial thus far?
"Yes, the information on clinicaltrials.gov is accurate - this study needs 40 more participants and is being hosted in 1 location. The trial started on February 5th 2020 and was most recently updated on December 2nd 2021."
What are some common reasons why a doctor would prescribe Venlafaxine?
"Venlafaxine is used to treat social anxiety and phobias. Additionally, it can be taken as a preventative measure for migraine headaches or to mitigate neuropathic pain and migraines."
Are new participants being accepted into this clinical trial at this time?
"That is correct, the clinicaltrials.gov website does say that this research is currently looking for volunteers. The trial was originally listed on February 5th 2020 and updated December 2nd 2021. This study needs 40 participants at 1 location."
Share this study with friends
Copy Link
Messenger